 "Dishman Pharma gains on 1:1 bonus")
Dishman Pharmaceuticals and Chemicals has rallied 7% to Rs 327 on the BSE in early morning trade after the board recommended a 1:1 bonus share subject to shareholders’ approval.
“The board of directors of the company at its meeting held on February 24, 2016, has recommended a bonus issue of equity shares in the ratio of 1 (one) equity share for every 1 (one) equity share held, as on the record date to be determined by the board,” Dishman Pharma said in a statement.
The board also approved scheme of arrangement and amalgamation amongst Dishman Pharmaceuticals and Chemicals, Dishman Care Limited (DCL) and Carbogen Amcis (India) Limited (CAIL).
At 09:26 AM, the stock was up 5% at Rs 320 on the BSE. A combined 463,144 shares changed hands on the counter on the BSE and NSE.
“The board of directors of the company at its meeting held on February 24, 2016, has recommended a bonus issue of equity shares in the ratio of 1 (one) equity share for every 1 (one) equity share held, as on the record date to be determined by the board,” Dishman Pharma said in a statement.
The board also approved scheme of arrangement and amalgamation amongst Dishman Pharmaceuticals and Chemicals, Dishman Care Limited (DCL) and Carbogen Amcis (India) Limited (CAIL).
At 09:26 AM, the stock was up 5% at Rs 320 on the BSE. A combined 463,144 shares changed hands on the counter on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%